Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Laurus Labs and Aspen Pharmacare launch an improved triple combination HIV drug in South Africa

Posted On: 2018-12-02 08:30:58

Laurus Labs, a leading integrated pharmaceutical company in India with presence across the globe and partner, Aspen Pharmacare, South Africa's leading pharmaceutical company, have launched a new HIV drug with the triple combination of Tenofovir Disoproxil Fumarate, Lamivudine and Dolutegravir (TLD) in South Africa on 26 November 2018.

Earlier, Aspen Pharma received approvals for the dossier where Aspen Port Elizabeth and Laurus Labs Visakhapatnam are registered as manufacturing facilities, from the South African Health Products Regulatory Authority (SAHPRA). Named Emdolten™, the product provides significant benefits to existing therapies, including countering drug resistance that often develops with older HIV treatments. This once-a-day triple combination tablet is positioned to become a preferred first-line ARV choice in multiple markets. It will be available in 50mg/300mg/300mg dosages.

As part of the partnership, Aspen launched the product in South Africa for the private market and Laurus Labs will supply the API, from its manufacturing facility located in Jawaharlal Nehru Pharma city, Visakhapatnam, India. This state-of-the-art facility is approved by USFDA.

Dr. Satyanarayana Chava, Founder and CEO, Laurus Labs said, "we convey our best wishes to our partner Aspen Pharma on the new product launch and we are happy to contribute to the treatment of millions of HIV patients across the globe through our fully integrated and the state of the art manufacturing facilities. I am sure that the new triple combination drug will contribute to the successful treatment of patients affected by HIV and AIDS."

Stavros Nicolaou, Senior Executive for Aspen Pharmacare stated "The Aspen Pharmacare and Laurus Labs intervention is one with an outstanding track record that has delivered millions of patient treatment packs to HIV infected patients on the African continent, Laurus Labs supplying the API and Aspen the ARV formulation. Through Emdolten™, which provides the latest ARV triple cocktail, cutting edge technology, many hundreds and thousands of patients will continue to benefit from the Aspen/Laurus intervention."

Shares of Laurus Labs Ltd was last trading in BSE at Rs.383 as compared to the previous close of Rs. 375.75. The total number of shares traded during the day was 2589 in over 103 trades.

The stock hit an intraday high of Rs. 386 and intraday low of 378. The net turnover during the day was Rs. 992502.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Punjab & Sind Bank declares Financial Results for the Quarter/ Year Ended 31.03.2019

Excel Industries Ltd Board approves Dividend of Rs. 18.75

NGL Fine-Chem Ltd board recommends final dividend of Rs. 1.75

NCC Ltd Board recommends Dividend of Rs. 1.50 for FY19

Dixon Technologies India Ltd Board recommends Final Dividend of Rs. 2

Housing and Urban Development Corporation Ltd Board approves Dividend for 2018-19

PNC Infratech Ltd Board approves Dividend of Rs. 0.50

Zuari Global Ltd Board recommends Dividend of Rs. 1 for 2018-19

BATA India Ltd Board recommends Dividend of Rs. 6.25 for FY19

Whirlpool of India Ltd Board recommends Dividend for FY 2018-19

Grasim Industries Ltd Board recommends Dividend of Rs. 7

Meghmani Organics Ltd Board recommends Final Dividend of Rs. 0.40 for FY19

Ashok Leyland Ltd Board recommends Dividend of Rs. 3.10

Pudumjee Paper Products Ltd Board approves Dividend of Rs. 0.15 for 2018-19

H G Infra Engineering Ltd Board approves Dividend of Rs. 0.50

Page Industries Ltd Board approves Dividend of Rs. 41

Ponni Sugars Erode Ltd board recommends Dividend of Rs. 2 for 2018-19

Kaira Can Co Ltd Board recommends Dividend of Rs. 6.50

Sudarshan Chemical Industries Ltd Board recommends Dividend of Rs. 6

Varroc Engineering Ltd announces Q4 & FY19 results

Zenith Fibres Ltd Board recommends Dividend for 2018-19

Varroc Engineering Ltd board recommends dividend of Rs. 4 for 2018-19

Ashoka Buildcon Limited Consolidated Revenue crossed Rs 5,000 Crores in FY19

Lancer Container Lines Ltd declares Q4, FY19 results

CG-VAK Software & Exports Ltd Board approves Dividend for FY 2018-19

DIL LTD Board recommends Final Dividend of Rs. 1.25

Welspun India Ltd Bord recommends Dividend of Rs. 0.30

HeidelbergCement India Ltd Board approves Dividend of Rs. 3

Vardhman Holdings Ltd board recommends dividend of Rs. 5 for FY19

Emmbi Industries Ltd Board recommends Dividend for 2018-19

Unichem Laboratories Ltd Board recommends Dividend of Rs. 4 for FY2018-19

Panama Petrochem Ltd Board recommends Dividend of Rs. 1.20 for FY19

Kaycee Industries Ltd Board recommends Dividend of Rs. 10 for 2018-19

Salzer Electronics Ltd board recommends dividend of Rs. 1.60 for 2018-19

AMJ Land Holdings Ltd Board approves Dividend of Rs. 0.30 for 2018-19

Empire Industries Ltd board recommends dividend of Rs. 25 for 2018-19

Advanced Enzyme Technologies Ltd announces Financial Results for the quarter and year ended March 2019

Kridhan Infra Ltd arm files for insolvency in Singapore

Infosys Completes Formation of Strategic Partnership with ABN AMRO in the Netherlands

Genesys International Corporation Ltd Board approves Dividend for 2018-19

I G Petrochemicals Ltd reports Q4, FY19 results

ITD Cementation India Ltd board recommends dividend of Rs. 0.40

Prima Plastics Ltd board approves dividend of Rs. 1 for FY19

Acrysil Ltd Board approves Dividend of Rs. 1.20

Munjal Auto Industries Ltd Board approves Dividend of Rs. 1

Ramco Systems FY19 revenue grows 16% and Net Profit by 45% in INR

IG Petrochemicals Ltd Board approves Dividend for FY19

Balaji Telefilms Ltd Board recommends Final Dividend for 2018-19

Sagar Cements Ltd Board recommends Dividend of Rs. 2.50

Asian Star Company Ltd board recommends dividend of Rs. 1.5







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019